CERT1 and cancer: Swanton et al. (2007) also observed that downregulation of COL4A3BP, besides sensitizing cancer cells to multiple cytotoxic agents, enhances ER stress, proposing COL4A3BP as a possible target in chemotherapy-resistant cancers.